MacroGenics, Inc. (NASDAQ: MGNX) has completed the sale of its good manufacturing practice (GMP) drug substance manufacturing operations to Bora ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE